Microcirculation SO
Microcirculation SO, licence 80058039: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nutragenius Inc.
- NPN or DIN-HM
- 80058039
- Status
- Inactive licence
- Licence date
- 10 February 2015
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de phoque Source : Blubber oil from harp seal (Pagophilus groenlandicus) Potency : 35.0 milligramme EPA | 500.0 milligramme | Not calculated |
| Huile de phoque Source : Blubber oil from harp seal (Pagophilus groenlandicus) Potency : 45.0 milligramme DHA | Not specified | Not calculated |
| Huile de phoque Source : Blubber oil from harp seal (Pagophilus groenlandicus) Potency : 25.0 milligramme DPA | Not specified | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 15.0 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Bactérie | 15.0 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Levure | 15.0 milligramme | Not calculated |
| Vaccinium angustifolium Source : Fruit Extraction ratio : 40:1 Dry plant equivalent : 400 milligramme | 10.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine, Eau purifiée, Tocopherols Excipient NF
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Softgel capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain and/or support cardiovascular health. Helps to support peripheral circulation. Helps to enhance memory in adults. Used in Herbal Medicine as a capillary/blood vessel protectant. Source of antioxidants for the maintenance of good health. Source of DHA and EPA (Omega-3 fatty acids) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058039
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.